Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Bichet

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic EfficacyAhsan Alam, Neera K Dahl, Joshua H Lipschutz, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Ethnic differences in renal responses to furosemideTae-Yon Chun, Lise Bankir, George J Eckert, et al.
Canadian Journal of Kidney Health and Disease|March 22, 2017
Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert ConsensusSteven Soroka, Ahsan Alam, Micheli Bevilacqua, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2022
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive MannerReema Habiby, Daniel G Bichet, Marie-Francoise Arthus, et al.
Canadian Journal of Kidney Health and Disease|October 23, 2018
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney DiseaseSteven Soroka, Ahsan Alam, Micheli Bevilacqua, et al.
Kidney International|August 31, 2012
Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremiaWilliam T Abraham, Guy Decaux, Richard C Josiassen, et al.
Molecular Genetics and Metabolism Reports|August 17, 2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry diseaseDaniel G Bichet, Roser Torra, Eric Wallace, et al.
Molecular Genetics and Metabolism Reports|December 22, 2021
Corrigendum to "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease" [Bichet et al., MGM Reports; 28 (2021) 100786]Daniel G Bichet, Roser Torra, Eric Wallace, et al.
The Journal of Physiology|April 21, 2010
New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytesAlexandre Leduc-Nadeau, Yoann Lussier, Marie-Françoise Arthus, et al.
Journal of the American Society of Nephrology : JASN|May 17, 2017
Hepatocyte Nuclear Factor-1<i>β</i> Regulates Urinary Concentration and Response to HypertonicityKaram Aboudehen, Lama Noureddine, Patricia Cobo-Stark, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic EfficacyAhsan Alam, Neera K Dahl, Joshua H Lipschutz, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Ethnic differences in renal responses to furosemideTae-Yon Chun, Lise Bankir, George J Eckert, et al.
Canadian Journal of Kidney Health and Disease|March 22, 2017
Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert ConsensusSteven Soroka, Ahsan Alam, Micheli Bevilacqua, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2022
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive MannerReema Habiby, Daniel G Bichet, Marie-Francoise Arthus, et al.
Canadian Journal of Kidney Health and Disease|October 23, 2018
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney DiseaseSteven Soroka, Ahsan Alam, Micheli Bevilacqua, et al.
Kidney International|August 31, 2012
Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremiaWilliam T Abraham, Guy Decaux, Richard C Josiassen, et al.
Molecular Genetics and Metabolism Reports|August 17, 2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry diseaseDaniel G Bichet, Roser Torra, Eric Wallace, et al.
Molecular Genetics and Metabolism Reports|December 22, 2021
Corrigendum to "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease" [Bichet et al., MGM Reports; 28 (2021) 100786]Daniel G Bichet, Roser Torra, Eric Wallace, et al.
The Journal of Physiology|April 21, 2010
New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytesAlexandre Leduc-Nadeau, Yoann Lussier, Marie-Françoise Arthus, et al.
Journal of the American Society of Nephrology : JASN|May 17, 2017
Hepatocyte Nuclear Factor-1<i>β</i> Regulates Urinary Concentration and Response to HypertonicityKaram Aboudehen, Lama Noureddine, Patricia Cobo-Stark, et al.
Pageof 15